What Doxper does

Doxper (legally InformDS Technologies Private Limited) is a Mumbai- and Bangalore-based digital health data-capture platform founded in 2015 by IIT alumni Shailesh Prithani (CEO), Randeep Singh (CSO), and Pawan Jain (CTO). The company provides an AI-powered digital pen and encoded paper solution that allows physicians to instantly digitise handwritten prescriptions and case sheets without changing their clinical workflow, addressing the long-standing failure of EHR/EMR systems to achieve adoption in outpatient settings. Underlying technology combines Bluetooth-enabled smart pens writing on PageID-coded paper with a proprietary in-house machine learning pipeline for medical handwriting recognition (~95% initial accuracy after per-physician calibration on 100-300 prescriptions), hosted on HIPAA-compliant cloud infrastructure and integrating with existing Hospital Information Systems (HIS/EMR) via real-time contextual triggers to departments such as Admissions, Lab, Pharmacy, and Imaging. Specialty-specific structured templates span 11 clinical specialties and the platform is fully integrated with India's Ayushman Bharat Digital Mission (ABDM) for ABHA health ID creation and record linking.

Doxper monetises through a multi-stream model: annual subscriptions at Rs 15,000 per pen licence (or Rs 1,500/month auto-pay), Rs 5,000 per additional specialty template, a Rs 4-6 consumable per-sheet charge on Doxper Prints encoded paper (MOQ 1,000), and a Rs 5,000 refundable pen security deposit. Go-to-market is bifurcated: a direct enterprise field-sales motion with custom HIS/EMR integration for hospitals (signed customers include Manipal Hospitals, Wockhardt, Nanavati Max, BLK Max, KIMS, CK Birla, and Cloudnine), and a self-serve online subscription funnel with a 30-day free trial for individual clinics. A separate Real World Data & Analytics revenue line sells anonymised longitudinal Rx datasets and RWE studies to pharmaceutical and healthcare-analytics clients. According to disclosed metrics, the platform has 10,000+ doctors and 80+ hospital customers across 100+ Indian cities, with 30M+ digitised prescriptions and 1.5 crore+ post-Meddo acquisition; operations extend to Bangladesh (3,000+ doctors via a pharma partnership) and historically Korea (e-pharmacy channel via K-Startup Grand Challenge in 2018).

The company has raised approximately US$5.85 million in total disclosed funding — a $750K seed (August 2017), $1.1M pre-Series A (April 2018), and $4M Series A first close (August 2019) led by Alkemi — and in August 2021 was acquired by Gurugram-based outpatient healthtech operator Meddo in a cash-and-stock deal, under which Doxper continues to operate as a branded product within Meddo's outpatient ecosystem. Doxper holds one granted Indian patent (WO2017119004) covering its healthcare informatics storage/delivery method and has been recognised via MIT Solve (2017), Nasscom Emerge50 (2018), and HIMSS-Elsevier Asia Pacific Digital Healthcare Award finalist status (2018).

Name

Doxper

Legal name

InformDS Technologies Private Limited

Website

https://doxper.com

Company type

Private

Founded year

2015

Operating status

Acquired

Headcount range

51–100 employees

Short description

Doxper (InformDS Technologies Private Limited) is an India-based AI-powered digital pen and encoded paper platform that lets physicians instantly digitise handwritten prescriptions and case sheets, serving hospitals, individual clinics, and pharmaceutical companies with ABDM-integrated clinical documentation and real-world data analytics.

Ownership category

akta.pro rank

Product category

Healthcare Documentation Software

NAICS

Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Pens, Pencils & Other Artists' Materials (3950)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

akta.pro secondary industries

Optical Character Recognition (OCR) & Document Vision (HDAAAEAD), DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)

Keywords

• Digital pen healthcare
• Medical handwriting recognition
• Healthcare data digitization
• Prescription digitization platform
• Clinical documentation software

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Marketing or Sales, Personnel, Operations, Supply Chain

Revenue model

1. Subscription Fees: Annual or monthly subscription plans for digital pen license with software access. Annual plan at Rs 15,000 per annum, monthly at Rs 1,500 per month. Includes pen warranty, cloud storage, software upgrades, and ABDM services.
2. Doxper Prints (Consumables): Revenue from encoded prescription paper sheets. Rs 4 for single-side A4, Rs 6 for double-side A4. Minimum order quantity 1000 prints with pan-India delivery.
3. Template Customisation: Additional revenue from template change fees or additional template designs at Rs 5,000 per template.
4. Pen Security Deposit: Refundable security deposit of Rs 5,000 for trial users, held until subscription conversion or pen return.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Doxper provides an AI-powered digital pen and encoded paper solution that allows doctors to digitise handwritten prescriptions and case sheets in real-time without changing their clinical workflow. The bundled offering includes a Bluetooth-enabled digital pen (Doxper and Doxper Blu), mobile applications, a HIPAA-compliant cloud platform with specialty-specific structured templates, and integration with India's Ayushman Bharat Digital Mission (ABDM).

Product overview

Doxper is a unified healthcare digitisation platform built around an ML/AI-powered digital pen and encoded paper solution. The core offering consists of the Doxper Digital Pen, DOXPER/DOXPER BLU mobile apps, and cloud-based health records platform. Specialty-specific coded paper templates support 11 medical specialties. The platform is offered through subscription plans (Classic Trial, Annual, Monthly) that bundle the pen hardware with software access, cloud storage, and ABDM services. Add-on modules include Real World Data & Analytics for pharma companies, Hospital Integration for HIS/EMR connectivity, Smart Contextual Triggers for automated care coordination, and MIS Dashboards for operational analytics. Doxper was acquired by Meddo in August 2021.

Differentiator

Problem solved

Functional benefit

Brands

• DOXPER: AI-powered digital pen and encoded paper solution for healthcare digitisation, enabling doctors to instantly digitise prescriptions and case sheets without workflow change.
• DOXPER BLU

Products and services

• Doxper Digital Pen & Cloud Digitisation Platform AI-powered digital pen (Doxper and Doxper Blu with Bluetooth) paired with mobile apps (DOXPER and DOXPER BLU) and a HIPAA-compliant cloud platform that captures handwritten prescriptions and case sheets in real-time via Bluetooth and stores them in a structured digital format. Sold via annual (Rs 15,000) or monthly (Rs 1,500) subscription for individual clinics and hospitals; 30-day free trial available.
• Doxper Encoded Paper (Doxper Prints) Coded/printed paper sheets with a unique PageID that work with the Doxper digital pen for handwriting capture. Available as single-side A4 (Rs 4) and double-side A4 (Rs 6) with a minimum order quantity of 1,000 prints and pan-India delivery. Offered with specialty-specific structured templates for Cardiology, Dental, Dermatology, ENT, Gynaecology, Internal Medicine, Neurology, Oncology, Ophthalmology, Paediatrics, and Psychiatry.
• Real World Data & Analytics Service Analytics service providing anonymised, unbiased, and longitudinal Rx insights from digitised outpatient prescriptions. Used by pharmaceutical companies for real-world evidence generation, Rx audits, brand performance tracking, KOL engagement, disease surveillance, and pharmacovigilance. Supports monthly anonymised Rx datasets and custom digitised Rx templates for therapy areas and geographies (e.g., Africa).
• ABDM Integration Services Integration with India's Ayushman Bharat Digital Mission enabling ABHA (Ayushman Bharat Health Account) creation and health records linking for patients. Included with subscriptions and offered as part of compliance enablement for participating healthcare providers. Doxper became one of the first tech players fully integrated with ABDM.

Quantifiable outcome

• 96% adoption rate within 6 weeks average
• +4 more outcomes

Named customers15 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature5 records

Partnerships

Six partnerships are on record, tiered minor, flagship and core.

• Eshwar Foundation & Welfare SocietyminorStrategic or Co-development Partner · 1 January 2023Social endeavour to bring quick and cost-effective healthcare digitisation to remote areas on outskirts of Bangalore.
• National Health Authority (NHA) - ABDMflagshipStrategic or Co-development Partner · 13 May 2022Doxper is one of the first tech players fully integrated with India's Ayushman Bharat Digital Mission (ABDM). Participates in NHA technology partner conventions to shape India's digital health ecosystem.
• MeddoflagshipStrategic or Co-development Partner · 3 August 2021Gurugram-based healthtech startup acquired Doxper in a cash and stock deal. Combined entity became one of India's largest healthtech players in outpatient care space with 1.5 crore+ digitised prescriptions and 1 crore+ patients.
• Pharma company partnerships (Bangladesh)coreChannel Partner/ Reseller/ Distributor · 1 June 2021Partnership with pharma company since June 2021 to sponsor Doxper solution for 3,000+ doctors in Bangladesh. Crossed 2 million Rx milestone. Scale-up to additional doctors.
• Korean e-pharmacy startupminorChannel Partner/ Reseller/ Distributor · 5 December 2018First major overseas order and partnership secured through K-Startup Grand Challenge programme. Partnership with fast-growing e-pharmacy startup in Korea.
• Biocon FoundationcoreStrategic or Co-development Partner · 16 February 2017Partnership for oral cancer screening at scale using Doxper's digital pen solution with ASHA workers. Data captured in local language (Kannada), analytics and insights generation provided. Over 5,000 patients screened.

Scale indicators17 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Practo: Practo is a broader digital health platform in India offering practice management, EMR, telemedicine, and appointments. While not a direct smart pen competitor, Practo competes in digitising Indian physicians' workflows and is a much larger incumbent in the same customer base.
• MFine: MFine is an Indian digital health platform offering online consultations, EMR, and AI-driven health services. Comparable as a healthcare IT player targeting Indian physicians and outpatient digitisation, though focused more on telehealth than handwriting capture.
• Napier Healthcare: Napier Healthcare provides hospital information systems and EMR solutions for hospitals across emerging markets including India. Comparable as a healthcare IT vendor competing for the same hospital digitisation RFPs as Doxper's enterprise offering.
• Tata 1mg (1mg): Tata 1mg is a leading Indian digital health platform with e-pharmacy, diagnostics, and physician consultation services. While broader than Doxper, it increasingly competes for outpatient digitisation workflows and physician data relationships.
• Attune Technologies: Attune Technologies is a cloud-based healthcare IT platform providing HIS/EMR solutions for hospitals across India and emerging markets. A direct competitor in the hospital digitisation space where Doxper's hospital integration module competes.

Direct peers

• DocOn: DocOn provides digital prescription and clinic management software for Indian doctors, including smart pen-based digitisation. Directly comparable to Doxper's clinic-focused digitisation offering, serving solo practitioners and small clinics in India.
• Livescribe: Livescribe pioneered smart pen and digitised paper technology for general note-taking, the same core technology category as Doxper's smart digital pen. While Livescribe is consumer/education-focused and Doxper is healthcare-focused, they share the underlying digitised handwriting capture approach.
• HealthStack (by Clairco): HealthStack provides digital health infrastructure including EMR/HIS solutions for Indian hospitals and clinics. Directly comparable as a healthcare digitisation platform targeting similar enterprise hospital customers as Doxper.

Emerging players

• CrelioHealth (formerly LiveHealth): CrelioHealth is a digital health platform focused on diagnostic centres and patient records management in India. Comparable as a healthtech platform serving outpatient and diagnostic workflows with overlap on patient data management.

Others

• Meddo: Meddo is Doxper's parent company (acquired Aug 2021), operating an integrated outpatient care platform. Relevant as the strategic acquirer/operator of Doxper's platform and a reference point for how Doxper's technology is being commercialised in a larger healthtech context.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@doxper1412/videos
• Facebookfacebook.com/doxper
• LinkedInlinkedin.com/company/doxper
• Xx.com/DoxperIndia

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doxper